Drug Type Small molecule drug |
Synonyms Lotamilast (USAN/INN), DMVT 501, E 6005 + [2] |
Target |
Mechanism PDE4 inhibitors(Phosphodieterase 4 inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC26H24N4O5 |
InChIKeyBBTFKAOFCSOZMB-UHFFFAOYSA-N |
CAS Registry947620-48-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dermatitis, Atopic | Phase 2 | US | Dermavant Sciences GmbHStartup | 01 Nov 2016 |
Dermatitis, Atopic | Phase 2 | JP | Dermavant Sciences GmbHStartup | 01 Nov 2016 |
Dermatitis, Atopic | Phase 2 | CA | Dermavant Sciences GmbHStartup | 01 Nov 2016 |